Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00002394 · ClinicalTrials.gov registry record · NA

Safety and Effectiveness of Giving Lamisil to HIV-Positive Subjects With Thrush Who Have Not Responded to Fluconazole Treatment

A NA study of HIV Infections and Candidiasis, Oral, sponsored by Novartis.

Completed
Registry status
NA
Development phase
30
Enrollment target
9
Study locations

NCT00002394 is a NA study of HIV Infections and Candidiasis, Oral that has completed, run by Novartis. The registered enrollment target is 30 participants, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (93% lower). The trial reports 9 study locations across 6 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00002394, a NA study of HIV Infections and Candidiasis, Oral, has completed, sponsored by Novartis.

COMPLETED
Registry status
NA
Development phase
30 participants
Enrollment target
9
Study locations

Study Summary

The purpose of this study is to see if it is safe and effective to give Lamisil to HIV-positive patients with thrush (a fungal infection) that has not responded to fluconazole.

Conditions Studied

HIV Infections Candidiasis, Oral

Interventions

  • DRUG Terbinafine hydrochloride

Study Locations (9)

Florida

  • Therafirst Med Ctr - Fort Lauderdale
  • Associates in Research - Fort Myers
  • Clireco Inc - Tamarac
  • Infectious Diseases Research Inc - Tampa

Illinois

  • Northwestern Univ / Division of Infectious Disease - Chicago

New Jersey

  • Saint Michaels Med Ctr / Infectious Disease Resch Dpt - Newark

New York

  • St Vincents Hosp / Clinical Research Program - New York

Texas

  • Univ of Texas Med Branch - Galveston

Virginia

  • Hampton Roads Med Specialists - Hampton

Trial Details

FieldValue
Enrollment Target 30 participants
Phase NA

Sponsor

Novartis

265 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00002394

The ClinicalTrials.gov registry entry for NCT00002394 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (93% lower). The listed sponsor is Novartis, which has 265 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with HIV Infections appearing as the primary indexed condition, and to 1 intervention - of which Terbinafine hydrochloride is the first listed.

NCT00002394 reports 9 study locations spanning 6 distinct geographic areas - top geographies include Florida, Illinois, New Jersey.

Frequently Asked Questions

What is clinical trial NCT00002394 about?

NCT00002394 is a clinical study titled "Safety and Effectiveness of Giving Lamisil to HIV-Positive Subjects With Thrush Who Have Not Responded to Fluconazole Treatment". The purpose of this study is to see if it is safe and effective to give Lamisil to HIV-positive patients with thrush (a fungal infection) that has not responded to fluconazole.

What is the current status of trial NCT00002394?

This trial is currently completed. It is a NA study. The enrollment target is 30 participants.

What conditions does trial NCT00002394 study?

This clinical trial studies the following conditions: HIV Infections, Candidiasis, Oral.

What interventions are being tested in trial NCT00002394?

The interventions under investigation include: Terbinafine hydrochloride (DRUG).

Who is sponsoring clinical trial NCT00002394?

This trial is sponsored by Novartis, which has 265 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00002394 being conducted?

This trial has 9 study locations across Florida, Illinois, New Jersey, New York, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for HIV Infections

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

HIV Infections

All registered trials for this condition

Candidiasis, Oral

All registered trials for this condition

Florida

All trials with a study site in Florida

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.